RESEARCHER PROFILE

Peter Paul De Deyn

← Back to University of Antwerp

P

University of Antwerp

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorCerebrospinal fluid and hydrocephalus

Peter Paul De Deyn works in Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Cerebrospinal fluid and hydrocephalus. Recorded institutional associations include University Medical Center Groningen, University of Antwerp, University of Groningen.

2,132Publications
48,166Citations
103H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Donanemab in Early Symptomatic Alzheimer Disease

    2023 · 2,861 citations

  2. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    2009 · 2,231 citations

  3. Applications of the Morris water maze in the study of learning and memory

    2001 · 2,040 citations

  4. Review on uremic toxins: Classification, concentration, and interindividual variability

    2003 · 1,720 citations

  5. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

    2006 · 1,511 citations

  6. APOE and Alzheimer disease: a major gene with semi-dominant inheritance

    2011 · 713 citations

  7. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

    1999 · 615 citations

  8. The complexity of neurobiological processes in acute ischemic stroke

    2009 · 526 citations

  9. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress

    2006 · 521 citations

  10. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

    2021 · 435 citations

  11. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

    2013 · 405 citations

  12. Neurological complications in renal failure: a review

    2004 · 396 citations

  13. Neuropsychiatric Syndromes in Dementia

    2007 · 383 citations

  14. Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target

    2019 · 372 citations

  15. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion

    2002 · 365 citations

  16. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

    2023 · 343 citations

  17. Cerebellar neurocognition: Insights into the bottom of the brain

    2008 · 342 citations

  18. The Lateralized Linguistic Cerebellum: A Review and a New Hypothesis

    2001 · 331 citations

  19. Decreased expression of the GABAA receptor in fragile X syndrome

    2006 · 317 citations

  20. Rapid Reconfiguration of the Functional Connectome after Chemogenetic Locus Coeruleus Activation

    2019 · 317 citations

  21. Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition

    2003 · 296 citations

  22. Monitoring of Physical Activity After Stroke: A Systematic Review of Accelerometry-Based Measures

    2010 · 293 citations

  23. PTZ-induced seizures in mice require a revised Racine scale

    2019 · 282 citations

  24. Phenotype of arylsulfatase A-deficient mice: Relationship to human metachromatic leukodystrophy

    1996 · 264 citations

  25. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia

    2007 · 257 citations

← Return to the university profile